Pradžia › Širdies vainikinių arterijų liga › Oklahoma
Širdies vainikinių arterijų liga klinikiniai tyrimai Oklahoma
7 tyrimai dėl Širdies vainikinių arterijų liga ieško dalyvių vietose Oklahoma.
Miestai Oklahoma
Oficialus tyrimo tekstas (anglų kalba)
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
- Oklahoma Heart Hillcrest Medical, Tulsa
Renkami dalyviai
Amžius nuo 18 iki 90 · Visoms lytims · Atnaujinta 2026-09-30 · NCT07296744Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- South Oklahoma Heart Research, LLC, Oklahoma City
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT06909565A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- South Oklahoma Heart Research, LLC, Oklahoma City
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07521007Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
- Oklahoma City VA Medical Center, Oklahoma City
- Oklahoma Heart Institute at Hillcrest Medical Center, Tulsa
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-19 · NCT02061436MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- University of Oklahoma Health Science Center, Oklahoma City
Renkami dalyviai
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2025-09-11 · NCT06271590Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
- Oklahoma Heart, Oklahoma City
Renkami dalyviai
Visi amžiai · Visoms lytims · Atnaujinta 2025-07-24 · NCT04634240MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- Oklahoma University Health (OU Health), Oklahoma City
Renkami dalyviai
Amžius nuo 18 iki 110 · Visoms lytims · Atnaujinta 2025-02-25 · NCT05908331Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.